Abstract
Purpose
Cyclin D1 (CCND1) is a key regulatory protein in the G1/S checkpoint of the cell cycle. We hypothesized that the G870A polymorphism of CCND1 is associated with the risk for cervical cancer and performed a meta-analysis of eligible studies to evaluate this relationship.
Methods
In a case–control study of 300 patients with newly diagnosed cervical cancer and 312 cancer-free controls who were frequency-matched by age, we genotyped the G870A polymorphism of CCND1 by polymerase chain reaction–restriction fragment length polymorphism (PCR–RFLP). A meta-analysis was performed using five case–control studies, including our results.
Results
No significant association was observed between the G870A polymorphism of CCND1 and cervical cancer risk. Further, in our meta-analysis, there was no significant risk of cervical cancer that correlated with the G870A polymorphism of CCND1. In the stratified analysis by race, however, individuals who harbored the AA or AA/AG genotypes were at significantly greater risk compared with GG carriers in the Asian population.
Conclusion
The G870A polymorphism in CCND1 may not contribute to the etiology of cervical cancer in Chinese populations.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CCND1:
-
Cyclin D1
- CI:
-
Confidence interval
- OR:
-
Odds ratio
- PCR–RFLP:
-
Polymerase chain reaction–restriction fragment length polymorphism
- SNPs:
-
Single-nucleotide polymorphisms
References
Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, Heighway J (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11:1005–1011
Catarino R, Matos A, Pinto D, Pereira D, Craveiro R, Vasconcelos A et al (2005) Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism. Cancer Genet Cytogenet 160:49–54
Catarino R, Pereira D, Breda E, Coelho A, Matos A, Lopes C et al (2008) Oncogenic virus-associated neoplasia: a role for cyclin D1 genotypes influencing the age of onset of disease? Biochem Biophys Res Commun 370:118–122
Ceschi M, Sun CL, Van Den Berg D, Koh WP, Yu MC, Probst-Hensch N (2005) The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis 26:1457–1464
Dhar KK, Branigan K, Howells RE, Musgrove C, Jones PW, Strange RC et al (1999) Prognostic significance of cyclin D1 gene (CCND1) polymorphism in epithelial ovarian cancer. Int J Gynecol Cancer 9:342–347
Doorbar J (2006) Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci (Lond) 110:525–541
Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD (1998) Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 338:423–428
Jeon YT, Kim JW, Song JH, Park NH, Song YS, Kang SB et al (2005) Cyclin D1 G870A polymorphism and squamous cell carcinoma of the uterine cervix in Korean women. Cancer Lett 223:259–263
Kang S, Kim JW, Park NH, Song YS, Kang SB, Lee HP et al (2005) Cyclin D1 polymorphism and the risk of endometrial cancer. Gynecol Oncol 97:431–435
Lu C, Dong J, Ma H, Jin G, Hu Z, Peng Y et al (2009) CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis. Breast Cancer Res Treat 116:571–575
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Roden R, Wu TC (2006) How will HPV vaccines affect cervical cancer? Nat Rev Cancer 6:753–763
Satinder K, Chander SR, Pushpinder K, Indu G, Veena J (2008) Cyclin D1 (G870A) polymorphism and risk of cervix cancer: a case control study in north Indian population. Mol Cell Biochem 315:151–157
Sawa H, Ohshima TA, Ukita H, Murakami H, Chiba Y, Kamada H et al (1998) Alternatively spliced forms of cyclin D1 modulate entry into the cell cycle in an inverse manner. Oncogene 16:1701–1712
Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA et al (2001) Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 286:3106–3114
Sherr CJ (1995) D-type cyclins. Trends Biochem Sci 20:187–190
Sherr CJ (1996) Cancer cell cycles. Science 274:1672–1677
Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, Lan Z et al (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278:30339–30347
Thakur N, Hussain S, Kohaar I, Tabassum R, Nasare V, Tiwari P et al (2009) Genetic variant of CCND1: association with HPV-mediated cervical cancer in Indian population. Biomarkers 14:219–255
Wen C et al (2005) China’s plans to curb cervical cancer. Lancet Oncol 6:139–141
Woodman CB, Collins S, Winter H, Bailey A, Ellis J, Prior P et al (2001) Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831–1836
Zur Hausen H (2002) Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2:342–350
Acknowledgments
This study was supported in part by the National Natural Science Foundation of China (30872084) and the Natural Science Foundation of Jiangsu Province (BK2006231 and BK2009418).
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
Jing Ni and Meilin Wang contributed equally.
Rights and permissions
About this article
Cite this article
Ni, J., Wang, M., Wang, M. et al. CCND1 G870A polymorphism and cervical cancer risk: a case–control study and meta-analysis. J Cancer Res Clin Oncol 137, 489–494 (2011). https://doi.org/10.1007/s00432-010-0904-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-010-0904-x